These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26827647)

  • 21. Preserved motor memory in Parkinson's disease.
    Lahlou S; Gabitov E; Owen L; Shohamy D; Sharp M
    Neuropsychologia; 2022 Mar; 167():108161. PubMed ID: 35041839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential optimal dopamine levels for set-shifting and working memory in Parkinson's disease.
    Fallon SJ; Smulders K; Esselink RA; van de Warrenburg BP; Bloem BR; Cools R
    Neuropsychologia; 2015 Oct; 77():42-51. PubMed ID: 26239947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feedback-Based Learning in Aging: Contributions and Trajectories of Change in Striatal and Hippocampal Systems.
    Lighthall NR; Pearson JM; Huettel SA; Cabeza R
    J Neurosci; 2018 Sep; 38(39):8453-8462. PubMed ID: 30120208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential role of dopamine in emotional attention and memory: evidence from Parkinson's disease.
    Hälbig TD; Assuras S; Creighton J; Borod JC; Tse W; Frisina PG; Voustianiouk A; Gracies JM; Olanow CW
    Mov Disord; 2011 Aug; 26(9):1677-83. PubMed ID: 21638322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism.
    Moustafa AA; Sherman SJ; Frank MJ
    Neuropsychologia; 2008 Nov; 46(13):3144-56. PubMed ID: 18687347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is impaired memory for spatial location in Parkinson's disease domain specific or dependent on 'strategic' processes?
    Pillon B; Deweer B; Vidailhet M; Bonnet AM; Hahn-Barma V; Dubois B
    Neuropsychologia; 1998 Jan; 36(1):1-9. PubMed ID: 9533382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A variable number of tandem repeats in the 3'-untranslated region of the dopamine transporter modulates striatal function during working memory updating across the adult age span.
    Sambataro F; Podell JE; Murty VP; Das S; Kolachana B; Goldberg TE; Weinberger DR; Mattay VS
    Eur J Neurosci; 2015 Aug; 42(3):1912-8. PubMed ID: 25997640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
    Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
    Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease.
    De Leonibus E; Managò F; Giordani F; Petrosino F; Lopez S; Oliverio A; Amalric M; Mele A
    Neuropsychopharmacology; 2009 Feb; 34(3):729-38. PubMed ID: 18704096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
    Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ
    Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease.
    Koerts J; Leenders KL; Koning M; Portman AT; van Beilen M
    Eur J Neurosci; 2007 May; 25(10):3132-6. PubMed ID: 17561826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motor procedural learning in Parkinson's disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinergic modulation of spatial learning, memory and navigation.
    Solari N; Hangya B
    Eur J Neurosci; 2018 Sep; 48(5):2199-2230. PubMed ID: 30055067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity.
    Bohnen NI; Gedela S; Herath P; Constantine GM; Moore RY
    Neurosci Lett; 2008 Dec; 447(1):12-6. PubMed ID: 18838108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novelty processing and memory formation in Parkinson's disease.
    Schomaker J; Berendse HW; Foncke EM; van der Werf YD; van den Heuvel OA; Theeuwes J; Meeter M
    Neuropsychologia; 2014 Sep; 62():124-36. PubMed ID: 25065495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease.
    Kim M; Cho KH; Shin MS; Lee JM; Cho HS; Kim CJ; Shin DH; Yang HJ
    Int J Mol Med; 2014 Apr; 33(4):870-8. PubMed ID: 24535622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
    Hanna-Pladdy B; Pahwa R; Lyons KE
    J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
    Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
    Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.